Raymond James Financial Services Advisors, Inc. Insmed Inc Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 24, 2023	BUY	$19.86 - $26.93 $820,952 - $1.11 Million	41,337 New	41,337 $1.04 Million
Q2 2019 Aug 06, 2019	SELL	$23.0 - $32.19 $201,181 - $281,565	-8,747 Closed	0 $0
Q1 2019 May 06, 2019	BUY	$13.91 - $31.15 $121,670 - $272,469	8,747 New	8,747 $254,000

Others Institutions Holding INSM

# of Institutions

482

Shares Held

182M

Call Options Held

2.27M

Put Options Held

3.32M

Vanguard Group Inc Valley Forge, PA

17.1M
Shares

$1.39 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

14.3M
Shares

$1.16 Billion
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

12.6M
Shares

$1.02 Billion
0.11% of portfolio
Darwin Global Management, Ltd. St. Helier, Y9

10.5M
Shares

$850 Million
62.32% of portfolio
Capital International Investors Los Angeles, CA

6.52M
Shares

$528 Million
0.09% of portfolio

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $11B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account